Background-Previous studies have suggested that coronary artery disease is independently associated with reduced cardiac parasympathetic activity, and that this is important in its pathophysiology. These studies included many patients with complications that might be responsible for the reported autonomic abnormalities. Objective-To measure cardiac parasympathetic activity in patients with uncomplicated coronary artery disease. Patients and methods-44 patients of mean (SD) age 56 (8) with severe uncomplicated coronary artery disease (symptoms uncontrolled on maximal medical treatment; > 70% coronary stenosis at angiography; normal ejection fraction; no evidence of previous infarction, diabetes, or hypertension). Heart rate variability was measured from 24 hour ambulatory electrocardiograms by counting the number of times successive RR intervals exceeded the preceding RR interval by > 50 ms, a previously validated sensitive and specific index of cardiac parasympathetic activity. Results-Mean (range) of counts were: waking 112 (range 6-501)/h, sleeping 198 (0-812)Ih, and total 3912 (151-14 454)/24 h. These mean results were unremarkable, and < 10% of patients feli below the lower 95% confidence interval for waking, sleeping, or total 24 hour counts in normal people. There was no relation between the severity of coronary artery disease or the use of concurrent antianginal drug treatment and cardiac parasympathetic activity. Conclusion-In contrast with previous reports no evidence of a specific independent association between coronary artery disease and reduced cardiac parasympathetic activity was found. The results of previous studies may reflect the inclusion of patients with complications and not the direct effect of coronary artery disease itself. (Br HeartJ 1994;71:515-520) The autonomic nervous system plays an important part in the pathophysiology of patients with ischaemic heart disease.' Acute myocardial infarction and impaired left ventricular function due to ischaemic heart disease are associated with abnormal autonomic
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The autonomic nervous system plays an important part in the pathophysiology of patients with ischaemic heart disease.' Acute myocardial infarction and impaired left ventricular function due to ischaemic heart disease are associated with abnormal autonomic function.2-' Hypertension, which commonly occurs in patients with coronary artery disease, is also independently associated with autonomic dysfunction. 6 Several studies suggest that coronary artery disease may be independently associated with a specific impairment of cardiac parasympathetic activity that occurs without sympathetic dysfunction.7-'0 Also, it has been suggested that the magnitude of parasympathetic dysfunction may be proportional to the severity of coronary artery disease, with the maximal impairment occurring in patients with three vessel disease.9 All of these studies, however, contained a substantial proportion of patients with complications relating to their coronary artery disease or associated disorders such as diabetes or hypertension. The abnormalities detected may therefore have been due predominantly to the effect of these other factors and not to an independent effect of coronary artery disease.
The principal aim of our study was to examine the hypothesis that coronary artery disease is associated with a specific independent impairment of cardiac parasympathetic activity by studying patients with symptomatic severe but uncomplicated coronary artery disease. We used our time domain technique of heart rate variability analysis. We also investigated the effect of severity of coronary artery disease and concurrent administration of antianginal drug treatment on cardiac parasympathetic activity.
Patients and methods

PATIENT SELECTION
Ambulant outpatients with severe angina pectoris were selected for our study. All patients had symptoms of at least three months duration that were uncontrolled despite optimal medical treatment (New York Heart Association functional class III or IV due to disabling angina). (8) 57 (6) 56 (9) Ejection fraction (%) 67 (7) 66 (6) 68 (7) 66 (8) End diastolic pressure (mm Hg) 13 (4) 13 (4) 14 (4) 13 (5) Time to 2 mm ST depression (s) 291 (120) 333 (94) 272 (129) 283 (125) Waking heart rate (beats/min) 64 (7) 67 (7) 62 (9) 63 (5) Sleeping heart rate (beats/min) 55 (8) 56 (9) 53 (7) 56 (8 Figure 4 shows the effect of the different antianginal drug treatments on total 24 hour counts. There were no significant differences in group mean total 24 hour counts when patients treated with ,B blockers were compared with those not receiving such treatment (p = 0 17). Similarly, calcium antagonists and nitrates had no significant effect on heart rate variability (p = 0-60 for the difference in mean counts in patients treated or not treated with calcium antagonists, p = 0-15 for difference in mean counts in patients treated or not treated with nitrates). Figure 5 shows the total 24 hour RR counts plotted according to the distribution of coronary artery disease. There were no significant differences in total 24 hour counts in patients with one, two or three vessel disease (F= 1-35, p = 0-271 Although the same authors reported a correlation between severity of coronary artery disease and the size of the reduction in heart rate variability,9 this is not supported by our study or other published work.78 This association may be due to the known presence of left ventricular impairment in the patients with multivessel disease. Airaksinen et al7 also reported impaired parasympathetic function in patients with coronary artery disease. If the analysis of their results is confined to patients free of segmental dyskinesia or akinesia, a group analogous to our own, three quarters of their patients have no evidence of parasympathetic dysfunction.
In common with other investigators, we continued antianginal drug treatment during our study.78 Although it might have been preferable to study our patients in a drug free state, we considered this to be unethical. Rich et al8 and Airaksinen et al7 reported considerable abnormalities of parasympathetic activity in patients with coronary artery disease who were receiving antianginal drug treatment, and our study design is similar apart from the exclusion of patients with complications known to be independently associated with autonomic abnormalities.
We have previously shown that our technique is sensitive enough to detect small drug induced changes in heart rate variability.152' The comparison of patients receiving different drug regimes (fig 4) enables us to draw some conclusions relating to the effect of antianginal drugs on cardiac parasympathetic activity. Calcium antagonists decrease sympathetically mediated components of heart rate variability but have no effect on parasympathetic activity, consistent with our results. 22 The effect of chronic oral nitrate treatment on cardiac parasympathetic activity has not previously been investigated. As there was no significant change in count rates in treated patients, chronic oral nitrate treatment does not seem to affect cardiac parasympathetic activity.
Treatment with /3 adrenergic blocking drugs produced only a small non-significant change in total 24 hour counts in our study. Other show any significant effect of long-term (four weeks) JJ blockade on parasympathetic activity.24 This is consistent with the findings of Bennet et al and Pagani et al who found that both long-term oral (12 month) and intravenous fi blockers had no effect on parasympathetic activity.19 25 Arousal level may also be important in modulating autonomic interactions. During most sleeping hours sympathetic activity is minimal. 26 We have previously shown that parasympathetic activity during sleeping hours, measured by our technique, is unaffected by fi blockade.'3 The finding of normal sleeping counts provides additional supporting evidence that our results were unaffected by ,B blockers. The net effect of fi blockers on parasympathetic activity depends on a complex interplay of many physiological factors. Our present finding that long-term treatment with ,B blockers has no effect on parasympathetic activity is consistent with previous work.
Autonomic function is normal before the onset of ischaemia.27 28 Acute ischaemic episodes are associated with short-term changes in heart rate variability29 that return to normal as the ischaemic episode resolves .30 This suggests that myocardial ischaemia, and not merely the presence of coronary artery disease, is associated with short term reversible changes in autonomic function. Also, relief of critical coronary obstruction by coronary angioplasty does not affect cardiac autonomic function.3' The studies of Hayano et a1910 were confined to the analysis of shortterm series and their measurements could be considerably distorted by intermittent changes such as those due to episodic myocardial ischaemia. As our method of analysis of heart rate variability measures parasympathetic activity over prolonged periods, it is unlikely to be greatly influenced by short episodic fluctuations in activity such as those occurring during myocardial ischaemia. Methods of testing autonomic reflexes that rely on stressing the cardiovascular system, as used by Airaksinen et Debate has recently centred around the relative contributions of coronary artery disease and left ventricular dysfunction to the reduced cardiac parasympathetic activity that occurs in patients with heart failure due to ischaemic heart disease." Our study shows that coronary artery disease is unlikely to contribute independently to autonomic dysfunction in heart failure. Where chronic heart failure accompanies coronary artery disease, any associated parasympathetic dysfunction is a result of left ventricular impairment alone.
In summary, we have used a time domain method of analysis of heart rate variability that is a sensitive and specific measure of cardiac parasympathetic activity to study ambulant outpatients with sympatomatic and severe, but uncomplicated coronary artery disease. In contrast with previous studies most of our patients showed no evidence of reduced cardiac parasympathetic activity. Also, we found no evidence of a relation between the severity of coronary artery disease and cardiac parasympathetic activity. We have confirmed that calcium antagonists and chronic oral nitrate treatment do not affect parasympathetic activity.
In the absence of overt myocardial ischaemia, previous myocardial infarction, or left ventricular dysfunction, coronary artery disease is not an independent cause of reduced cardiac parasympathetic activity.
